Application of visante optical coherence tomography tear meniscus height measurement in the diagnosis of dry eye disease

Clicks: 446
ID: 117926
2010
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #6 of 32 articles by views in ophthalmology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The Visante OCT is a quick, noninvasive method for assessing the TMH, with acceptable sensitivity, specificity, and repeatability, and may have potential applications for the diagnosis and evaluation of dry eye disease.
Reference Key
om2010ophthalmologyapplication Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Ibrahim OM;Dogru M;Takano Y;Satake Y;Wakamatsu TH;Fukagawa K;Tsubota K;Fujishima H;;
Journal ophthalmology
Year 2010
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/20605216
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine reproducibility of results research support non-u.s. gov't female male middle aged Prospective Studies Tomography sensitivity and specificity tears / chemistry* optical coherence* controlled clinical trial roc curve dry eye syndromes / diagnosis* pmid:20605216 doi:10.1016/j.ophtha.2010.01.057 osama m a ibrahim murat dogru hiroshi fujishima

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.